Steward Partners Investment Advisory’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92K Hold
500
﹤0.01% 4068
2025
Q4
$1.85K Hold
500
﹤0.01% 3979
2025
Q3
$7.06K Sell
500
-660
-57% -$10.3K ﹤0.01% 3537
2025
Q2
$22.3K Hold
1,160
﹤0.01% 2870
2025
Q1
$12.8K Hold
1,160
﹤0.01% 2987
2024
Q4
$19.3K Hold
1,160
﹤0.01% 2817
2024
Q3
$11.8K Buy
1,160
+1,000
+625% +$29.7K ﹤0.01% 2884
2024
Q2
$9.24K Hold
160
﹤0.01% 2845
2024
Q1
$5.33K Buy
+160
New +$8.1K ﹤0.01% 3023

Other funds holding OM

Steward Partners Investment Advisory's OM Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Outset Medical (OM) position steady in Q1 2026 at 500 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #4068.

Steward Partners Investment Advisory first reported a position in OM in Q1 2024 and has held it in 9 quarters since. The position peaked at $22.3K in Q2 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Steward Partners Investment Advisory held 500 shares of Outset Medical worth $1.92K as of Q1 2026.
  • Steward Partners Investment Advisory left its Outset Medical share count unchanged in Q1 2026.
  • Outset Medical made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4068 holding.
  • Steward Partners Investment Advisory first reported a position in Outset Medical in Q1 2024 and has held it in 9 quarters since.
  • Steward Partners Investment Advisory's Outset Medical position peaked at $22.3K in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.